Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Prolactin may be important for skin growth and immune function.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Adrenal disorders can cause lasting brain and behavior issues in children.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride may help some women with hair loss, but better options exist.

SHBG binding properties are unchanged in male liver cirrhosis patients.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Using neurohormones to control keratin can lead to new skin disease treatments.